NEW YORK (GenomeWeb News) - Bruker BioSciences said today that it closed its acquisition of molecular spectroscopy company Bruker Optics on July 1.
 
The $135 million purchase price was paid approximately 59 percent in cash and 41 percent in Bruker BioSciences stock. The company said that it issued around 11.4 million new shares for the stock component of the purchase.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.